His primary areas of study are Immunology, Microbiology, Antibody, Virulence and Cryptococcus neoformans. His is doing research in Immunity, Cryptococcosis, Immune system, Immunization and Opportunistic infection, both of which are found in Immunology. Liise Anne Pirofski works mostly in the field of Microbiology, limiting it down to topics relating to Mimotope and, in certain cases, Immunogen, Tetanus, Toxoid and Immunogenicity, as a part of the same area of interest.
His Antibody research includes themes of Antigen and Immunotherapy. His biological study spans a wide range of topics, including Pathogen, Pathogenicity, Host, Disease and Microbial pathogenesis. In his research on the topic of Cryptococcus neoformans, Virology, Interleukin 12 and Alveolar macrophage is strongly related with Immunoglobulin M.
Liise Anne Pirofski mostly deals with Immunology, Antibody, Microbiology, Cryptococcus neoformans and Virology. Many of his studies on Immunology involve topics that are commonly interrelated, such as Disease. Antibody is closely attributed to Antigen in his research.
In his research, Pathogen, Microbial pathogenesis and Pathogenicity is intimately related to Virulence, which falls under the overarching field of Microbiology. Liise Anne Pirofski interconnects Serology, Idiotype, Cryptococcosis and B cell in the investigation of issues within Cryptococcus neoformans. His Virology research includes elements of Pneumococcal vaccine and Severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019.
His primary scientific interests are in Antibody, Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2, Immunology and Pandemic. His research in Antibody intersects with topics in Immune system and Cryptococcus neoformans. His Cryptococcus neoformans research is under the purview of Microbiology.
His research investigates the link between Immunology and topics such as Pneumonia that cross with problems in Immunization. Liise Anne Pirofski has researched Pandemic in several fields, including Vaccination and Intensive care medicine. His Virology study which covers Monoclonal antibody that intersects with Serotype.
His scientific interests lie mostly in Antibody, Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2, Internal medicine and Pandemic. His Antibody study results in a more complete grasp of Immunology. His Immunology study frequently draws parallels with other fields, such as Cryptococcus neoformans.
He focuses mostly in the field of Coronavirus disease 2019, narrowing it down to topics relating to MEDLINE and, in certain cases, Outcome data. His Severe acute respiratory syndrome coronavirus 2 study incorporates themes from Computational biology, Antigenic analysis, Replication and Cell entry. Liise Anne Pirofski combines subjects such as Immunization, Viral load and Pneumonia with his study of Pandemic.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The convalescent sera option for containing COVID-19.
Arturo Casadevall;Liise Anne Pirofski.
Journal of Clinical Investigation (2020)
Host-Pathogen Interactions: Redefining the Basic Concepts of Virulence and Pathogenicity
Arturo Casadevall;Liise Anne Pirofski.
Infection and Immunity (1999)
Deployment of convalescent plasma for the prevention and treatment of COVID-19.
Evan M. Bloch;Shmuel Shoham;Arturo Casadevall;Bruce S. Sachais.
Journal of Clinical Investigation (2020)
Passive antibody therapy for infectious diseases
Arturo Casadevall;Ekaterina Dadachova;Liise Anne Pirofski.
Nature Reviews Microbiology (2004)
The damage-response framework of microbial pathogenesis
Arturo Casadevall;Liise Anne Pirofski.
Nature Reviews Microbiology (2003)
Host-pathogen interactions: basic concepts of microbial commensalism, colonization, infection, and disease.
Arturo Casadevall;Liise Anne Pirofski.
Infection and Immunity (2000)
Host‐Pathogen Interactions: The Attributes of Virulence
Arturo Casadevall;Liise anne Pirofski.
The Journal of Infectious Diseases (2001)
Serologic evidence for Cryptococcus neoformans infection in early childhood.
David L. Goldman;Hnin Khine;Jacob Abadi;Dania J. Lindenberg.
Pediatrics (2001)
Characterization of a Murine Monoclonal Antibody to Cryptococcus neoformans Polysaccharide That Is a Candidate for Human Therapeutic Studies
Arturo Casadevall;Wendy Cleare;Marta Feldmesser;Aharona Glatman-Freedman.
Antimicrobial Agents and Chemotherapy (1998)
A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens
Arturo Casadevall;Liise anne Pirofski.
Advances in Immunology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Johns Hopkins University
Mayo Clinic
Albert Einstein College of Medicine
Chinese Academy of Sciences
Baylor College of Medicine
Albert Einstein College of Medicine
Michigan State University
Max Planck Society
Albert Einstein College of Medicine
Mayo Clinic
ETH Zurich
Leipzig University
Yangzhou University
University of Montpellier
University of North Carolina at Chapel Hill
Royal Institute of Technology
Karolinska Institute
Murdoch University
Wageningen University & Research
All India Institute of Medical Sciences
University of California, San Francisco
Johns Hopkins University Applied Physics Laboratory
King's College London
Grenoble Alpes University
Université Paris Cité
Purdue University West Lafayette